Rise in prevalence of mycoplasmal infections is fueling the mycoplasma diagnostics market size. A common result of mycoplasma infection is pneumonia. Mycoplasma pneumonia is a common cause of community-acquired pneumonia.
R&D of rapid diagnosis tests is driving the mycoplasma diagnostics market revenue. Newly developed colloidal gold assays are effective in detecting mycoplasma pneumonia in clinical practice.
Key players in the global mycoplasma diagnostics market are seeking to facilitate easy and rapid diagnosis of mycoplasma pneumonia. To achieve this, they are offering ultrasensitive, rapid, and simple fluorescence microscopic assays for the visual identification of mycoplasma infection in laboratory cell cultures.
Mycoplasma is a bacterium (or germ) that can infect different parts of the human body. Mycoplasma diagnostics is a class of medical tests or examinations conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples.
Mycoplasma diagnostics is considered a rapidly evolving and fast-growing segment in the in vitro diagnostic sector. Usually, usage of molecular diagnostics was limited due to the necessity of vastly skilled specialists and the high cost of tests.
However, the decline in cost per sample analysis and labor cost, improvements in automation, and the introduction of advanced technologies have extended the usage of molecular diagnostics in a wide range of applications.
| Attribute | Detail |
|---|---|
| Drivers |
|
Mycoplasma genitalium is an emerging cause of genital discharge. The prevalence of mycoplasma genitalium infection varies widely in different countries. Studies conducted in Western Europe, North America, and Australia have estimated the prevalence of the disease in men to range between 1% and 3.3% and among women to range between 1% and 6.4%
The global mycoplasma diagnostics market has expanded in the last few decades since the entry of the Polymerase Chain Reaction (PCR).
DNA probes consisting of cloned ribosomal RNA genes, cDNA to mycoplasmal rRNA, synthetic 16S rRNA oligonucleotide sequences, or cloned mycoplasmal protein genes, are applied as diagnostic tools in a variety of human and animal mycoplasma infections.
PCR combined with serology offers a reliable and accurate diagnosis of mycoplasma pneumonia.
Mycoplasma pneumonia causes community-acquired pneumonia in children. It causes up to 40% of community-acquired pneumonia in children and about 18% of infections in patients requiring hospitalization. Such a scenario has led to the R&D of rapid tests for the diagnosis of mycoplasma infections.
This, in turn, is contributing to the mycoplasma diagnostics growth. Nucleic acid amplification techniques are currently considered a promising alternative method for rapid diagnosis of mycoplasma pneumonia infections.
Moreover, newly developed immuno-chromatographic antigen assays are a rapid, sensitive, and specific method for identifying mycoplasma pneumonia. These assays offer potential in the early diagnosis of the infection.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America dominated the mycoplasma diagnostics market share. Presence of large number of big research laboratories and surge in cases of mycoplasma pneumonia infections are fueling the market dynamics of the region. A rise in mycoplasma pneumonia infection was reported in Ohio, U.S. in 2023.
According to the latest mycoplasma diagnostics market analysis, the industry in Asia Pacific is expected to grow at a steady pace in the near future. The region has witnessed rise in cases of respiratory tract infection in the recent past. Surge in expenditure on healthcare infrastructure is also boosting the mycoplasma diagnostics industry revenue in Asia Pacific.
In a January 2024 study published in the journal Eurosurveillance, a team of researchers from the Netherlands reported on the recent increase in mycoplasma pneumonia infections in the country. In 2023, 133 patients with M. pneumonia-positive PCR were detected in Spaarne Gasthuis, with a median age of 28 years.
41.3% of patients were younger than 18 years, with most children in the age category 5-11 years. Hence, recent increase in mycoplasma pneumonia infections is driving mycoplasma diagnostics market statistics in Europe.
Vendors in the market landscape are offering products that utilize the polymerase chain reaction (PCR) for the highest sensitivity in the detection of mycoplasma and acholeplasma contamination in cell cultures and other cell culture-derived biologicals.
F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius AG, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck & Co., Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., and PromoCell GmbH are players operating in this mycoplasma diagnostics industry.
These companies have been profiled in the mycoplasma diagnostics market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 1.0 Bn |
| Market Forecast (Value) in 2034 | US$ 2.1 Bn |
| Growth Rate (CAGR) | 7.4% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.0 Bn in 2023
It is anticipated to grow at a CAGR of 7.4% from 2024 to 2034
Rise in prevalence of mycoplasmal infections and R&D of rapid diagnosis tests
North America was the leading region in 2023
F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius AG, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck & Co., Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., and PromoCell GmbH
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Mycoplasma Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Mycoplasma Diagnostics Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Mycoplasma Diagnostics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Kits & Reagents
6.3.2. Instruments
6.3.3. Software & Services
6.4. Market Attractiveness Analysis, by Product
7. Global Mycoplasma Diagnostics Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. PCR
7.3.2. Immunoassay
7.3.2.1. ELISA
7.3.2.2. RIA
7.3.3. DNA Staining
7.3.4. Microbial Culture Techniques
7.3.5. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Mycoplasma Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Direct Sales
8.3.2. Distributors
8.4. Market Attractiveness Analysis, by End-user
9. Global Mycoplasma Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Mycoplasma Diagnostics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2020-2034
10.3.1. Kits & Reagents
10.3.2. Instruments
10.3.3. Software & Services
10.4. Market Value Forecast, by Technology, 2020-2034
10.4.1. PCR
10.4.2. Immunoassay
10.4.2.1. ELISA
10.4.2.2. RIA
10.4.3. DNA Staining
10.4.4. Microbial Culture Techniques
10.4.5. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Direct Sales
10.5.2. Distributors
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Technology
10.7.3. By End-user
10.7.4. By Country
11. Europe Mycoplasma Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2020-2034
11.3.1. Kits & Reagents
11.3.2. Instruments
11.3.3. Software & Services
11.4. Market Value Forecast, by Technology, 2020-2034
11.4.1. PCR
11.4.2. Immunoassay
11.4.2.1. ELISA
11.4.2.2. RIA
11.4.3. DNA Staining
11.4.4. Microbial Culture Techniques
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Direct Sales
11.5.2. Distributors
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Technology
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Mycoplasma Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2020-2034
12.3.1. Kits & Reagents
12.3.2. Instruments
12.3.3. Software & Services
12.4. Market Value Forecast, by Technology, 2020-2034
12.4.1. PCR
12.4.2. Immunoassay
12.4.2.1. ELISA
12.4.2.2. RIA
12.4.3. DNA Staining
12.4.4. Microbial Culture Techniques
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Direct Sales
12.5.2. Distributors
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Technology
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Mycoplasma Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2020-2034
13.3.1. Kits & Reagents
13.3.2. Instruments
13.3.3. Software & Services
13.4. Market Value Forecast, by Technology, 2020-2034
13.4.1. PCR
13.4.2. Immunoassay
13.4.2.1. ELISA
13.4.2.2. RIA
13.4.3. DNA Staining
13.4.4. Microbial Culture Techniques
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Direct Sales
13.5.2. Distributors
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Technology
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Mycoplasma Diagnostics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2020-2034
14.3.1. Kits & Reagents
14.3.2. Instruments
14.3.3. Software & Services
14.4. Market Value Forecast, by Technology, 2020-2034
14.4.1. PCR
14.4.2. Immunoassay
14.4.2.1. ELISA
14.4.2.2. RIA
14.4.3. DNA Staining
14.4.4. Microbial Culture Techniques
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Direct Sales
14.5.2. Distributors
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Technology
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Agilent Technologies
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Sartorius AG
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Savyon Diagnostics
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Takara Bio Inc. (Takara Holding Company Inc.)
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Lonza Group
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Merck & Co., Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Charles River Laboratories International, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Thermo Fisher Scientific Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. PromoCell GmbH
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 02: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 03: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 07: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 08: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 11: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 12: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 15: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 16: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 19: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 20: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 23: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2020-2034
Table 24: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Mycoplasma Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Mycoplasma Diagnostics Market Revenue (US$ Mn), by Product, 2023
Figure 03: Global Mycoplasma Diagnostics Market Value Share, by Product, 2023
Figure 04: Global Mycoplasma Diagnostics Market Revenue (US$ Mn), by Technology, 2023
Figure 05: Global Mycoplasma Diagnostics Market Value Share, by Technology, 2023
Figure 06: Global Mycoplasma Diagnostics Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global Mycoplasma Diagnostics Market Value Share, by End-user, 2023
Figure 08: Global Mycoplasma Diagnostics Market Value Share, by Region, 2023
Figure 09: Global Mycoplasma Diagnostics Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
Figure 11: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 13: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
Figure 14: Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Mycoplasma Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Mycoplasma Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
Figure 22: North America Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 23: North America Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
Figure 26: North America Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
Figure 31: Europe Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 32: Europe Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
Figure 35: Europe Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
Figure 40: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 41: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
Figure 44: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Mycoplasma Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
Figure 49: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 50: Latin America Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
Figure 53: Latin America Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by Product, 2023 and 2034
Figure 58: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2023 and 2034
Figure 59: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology, 2024-2034
Figure 62: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Mycoplasma Diagnostics Market
